Search for other papers by Qingrong Pan in
Google Scholar
PubMed
Search for other papers by Shuxin Gao in
Google Scholar
PubMed
Search for other papers by Xia Gao in
Google Scholar
PubMed
Search for other papers by Ning Yang in
Google Scholar
PubMed
Search for other papers by Zhi Yao in
Google Scholar
PubMed
Search for other papers by Yanjin Hu in
Google Scholar
PubMed
Search for other papers by Li Miao in
Google Scholar
PubMed
Search for other papers by Zhe Chen in
Google Scholar
PubMed
Search for other papers by Guang Wang in
Google Scholar
PubMed
speculated that the increase of Hcy was at least partially due to the decrease of renal function ( 15 ), because of the evidence that Hcy was negatively correlated with kidney function in general population ( 16 , 17 , 18 ). However, it is unknown whether
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Anna C van der Burgh in
Google Scholar
PubMed
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Samer R Khan in
Google Scholar
PubMed
Search for other papers by Sebastian J C M M Neggers in
Google Scholar
PubMed
Search for other papers by Ewout J Hoorn in
Google Scholar
PubMed
Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands
Search for other papers by Layal Chaker in
Google Scholar
PubMed
Introduction Chronic kidney disease (CKD) is a highly prevalent condition ( 1 ) and is often characterized by a decline in kidney function over time. Generally, a higher prevalence of CKD is found in women, while men with CKD have a higher
Search for other papers by L E Zijlstra in
Google Scholar
PubMed
Search for other papers by D M van Velzen in
Google Scholar
PubMed
Search for other papers by S Simsek in
Google Scholar
PubMed
Search for other papers by S P Mooijaart in
Google Scholar
PubMed
Department of Internal Medicine, HagaHospital, The Hague, The Netherlands
Search for other papers by M van Buren in
Google Scholar
PubMed
Search for other papers by D J Stott in
Google Scholar
PubMed
Search for other papers by I Ford in
Google Scholar
PubMed
Search for other papers by J W Jukema in
Google Scholar
PubMed
Department of Internal Medicine, Section of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands
Search for other papers by S Trompet in
Google Scholar
PubMed
function to a lower estimated glomerular filtration rate (eGFR) and increased prevalence of CKD ( 10 , 11 , 12 ). Longitudinal studies have presented conflicting results, linking kidney function decline to low ( 13 ) or high thyroid function ( 14
Clinical Cooperation Group Diabetes, LMU München and Helmholtz Zentrum München, Munich, Germany
Search for other papers by Cornelia Then in
Google Scholar
PubMed
Search for other papers by Holger Then in
Google Scholar
PubMed
Clinical Cooperation Group Diabetes, LMU München and Helmholtz Zentrum München, Munich, Germany
German Center for Diabetes Research (DZD), München-Neuherberg, Germany
Search for other papers by Andreas Lechner in
Google Scholar
PubMed
Institute of Epidemiology, Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Neuherberg, Germany
Search for other papers by Cornelia Huth in
Google Scholar
PubMed
Chair of Epidemiology at UNIKAT Augsburg, Ludwig-Maximilians-Universität München, Munich, Germany
Search for other papers by Christa Meisinger in
Google Scholar
PubMed
KORA Study Center, University Hospital Augsburg, Augsburg, Germany
Search for other papers by Margit Heier in
Google Scholar
PubMed
Institute of Epidemiology, Helmholtz Zentrum München – German Research Center for Environmental Health (GmbH), Neuherberg, Germany
DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany
Search for other papers by Annette Peters in
Google Scholar
PubMed
Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany
Deutsches Herzzentrum München, Technische Universität München, Munich, Germany
Search for other papers by Wolfgang Koenig in
Google Scholar
PubMed
Search for other papers by Wolfgang Rathmann in
Google Scholar
PubMed
Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Search for other papers by Christian Herder in
Google Scholar
PubMed
Institute of Clinical Diabetology, German Diabetes Center, Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Division of Endocrinology and Diabetology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
Search for other papers by Michael Roden in
Google Scholar
PubMed
Search for other papers by Jürgen Scherberich in
Google Scholar
PubMed
Clinical Cooperation Group Diabetes, LMU München and Helmholtz Zentrum München, Munich, Germany
Search for other papers by Jochen Seissler in
Google Scholar
PubMed
clinical diagnosis, since obesity and other components of the metabolic syndrome, such as elevated fasting glucose and elevated blood pressure, are associated with glomerular hyperfiltration. The currently available kidney function markers (creatinine
Search for other papers by Adriana J van Ballegooijen in
Google Scholar
PubMed
Department of Health Sciences, Department of Epidemiology and Biostatistics, Department of Public Health, Department of General Practice, Department of Internal Medicine and Cardiovascular Research Institute Maastricht, Department of Internal Medicine, Faculty of Earth and Life Sciences, EMGO Institute for Health and Care Research, VU University Amsterdam, De Boelelaan 1085, 1081 HV Amsterdam, The Netherlands
Search for other papers by Marjolein Visser in
Google Scholar
PubMed
Search for other papers by Marieke B Snijder in
Google Scholar
PubMed
Search for other papers by Jacqueline M Dekker in
Google Scholar
PubMed
Search for other papers by Giel Nijpels in
Google Scholar
PubMed
Search for other papers by Coen D A Stehouwer in
Google Scholar
PubMed
Search for other papers by Michaela Diamant in
Google Scholar
PubMed
Search for other papers by Ingeborg A Brouwer in
Google Scholar
PubMed
)D and PTH in relation to kidney function is well-known, whereas the relationship with BNP is novel (11) . Observational data in patients with HF suggest that low 25(OH)D levels and high PTH levels are common and are both associated with higher BNP
Search for other papers by Merlin C Thomas in
Google Scholar
PubMed
Search for other papers by Brendon L Neuen in
Google Scholar
PubMed
Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, NSW, Australia
Search for other papers by Stephen M Twigg in
Google Scholar
PubMed
Search for other papers by Mark E Cooper in
Google Scholar
PubMed
Department of Renal Medicine, St George Hospital, Sydney, NSW, Australia
Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia
Search for other papers by Sunil V Badve in
Google Scholar
PubMed
effective means to protect kidney function in patients with T2D. Although SGLT2 inhibitors achieve urinary glucose wasting and were initially developed as glucose-lowering agents for the treatment of T2D, this represents only one of their potential
Search for other papers by Eliana Piantanida in
Google Scholar
PubMed
Search for other papers by Daniela Gallo in
Google Scholar
PubMed
Research Center in Epidemiology and Preventive Medicine (EPIMED), University of Insubria, Varese, Italy
Search for other papers by Giovanni Veronesi in
Google Scholar
PubMed
Search for other papers by Eugenia Dozio in
Google Scholar
PubMed
Search for other papers by Eugenia Trotti in
Google Scholar
PubMed
Search for other papers by Adriana Lai in
Google Scholar
PubMed
Search for other papers by Silvia Ippolito in
Google Scholar
PubMed
Search for other papers by Jessica Sabatino in
Google Scholar
PubMed
Search for other papers by Maria Laura Tanda in
Google Scholar
PubMed
Search for other papers by Antonio Toniolo in
Google Scholar
PubMed
Research Center in Epidemiology and Preventive Medicine (EPIMED), University of Insubria, Varese, Italy
Search for other papers by Marco Ferrario in
Google Scholar
PubMed
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
Objective
The aim of this observational study was to clarify the link between vitamin D status and metabolic syndrome (MetS) in people with visceral obesity.
Design and methods
One hundred ninety-six consecutive patients (152 women; mean age 51 ± 13 years) with visceral obesity (mean body weight 103 ± 20 kg, mean waist circumference (WC) 119 ± 13 cm) were enrolled at the Obesity Outpatient Clinic of the University of Insubria in Varese. Anthropometric measurements were recorded. Laboratory tests, including vitamin D (25(OH)D)), fasting blood glucose (FBG), lipid profile, liver and kidney function tests were assessed. Vitamin D status was defined according to the European Society of Endocrinology guidelines, MetS to the 2009 harmonized definition.
Results
An inverse association emerged among 25(OH)D, body mass index (BMI) (P = 0.001) and WC (all P = 0.003). Serum 25(OH)D levels were inversely related to FBG and systolic blood pressure (SBP) (respectively, P = 0.01 and 0.02). Median serum 25(OH)D levels were 13.3 ng/mL (CI 95% 12; 15) in MetS and 16 ng/mL (CI 95% 14; 18) (P = 0.01) in non-MetS patients. Among patients with MetS, lower 25(OH)D concentrations were related to higher risk of hypertension (HT) (odds ratio (OR) 1.7, CI 95%, 0.7;4) and hyperglycemia (IFG)/type 2 diabetes (OR 5.5, CI 95% 2; 14).
Conclusion
Vitamin D status and MetS are inversely correlated in visceral obesity, particularly with regard to glucose homeostasis and BP. More extensive studies are required to investigate the potential for causality.
Search for other papers by Yinqiong Huang in
Google Scholar
PubMed
Department of Endocrinology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China
Search for other papers by Zhaozhao Zhu in
Google Scholar
PubMed
Search for other papers by Zhiqin Huang in
Google Scholar
PubMed
Search for other papers by Jingxiong Zhou in
Google Scholar
PubMed
.115 0.024 a a P < 0.05, b P < 0.01. Linear correlation analysis between serum TMAO and kidney function First, we analyzed the correlation between serum TMAO and kidney function in all subjects. Spearman correlation analysis
Search for other papers by Martine Cohen-Solal in
Google Scholar
PubMed
Search for other papers by Thomas Funck-Brentano in
Google Scholar
PubMed
Department of Renal Physiology, Necker Hospital, Université de Paris, Paris, France
Search for other papers by Pablo Ureña Torres in
Google Scholar
PubMed
cohort of 1426 participants followed for a mean of 4.7 years, including 199 with eGFR <60 mL/mn/1.73 m 2 , low TBS score was independently associated with increased fracture risk in adults with reduced kidney function ( 35 ). High
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Yutong Zou in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Lijun Zhao in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Junlin Zhang in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Yiting Wang in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Yucheng Wu in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Honghong Ren in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Tingli Wang in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Rui Zhang in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Jiali Wang in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Yuancheng Zhao in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Chunmei Qin in
Google Scholar
PubMed
Search for other papers by Huan Xu in
Google Scholar
PubMed
Search for other papers by Lin Li in
Google Scholar
PubMed
Search for other papers by Zhonglin Chai in
Google Scholar
PubMed
Search for other papers by Mark E Cooper in
Google Scholar
PubMed
Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Nanwei Tong in
Google Scholar
PubMed
Laboratory of Diabetic Kidney Disease, Centre of Diabetes and Metabolism Research, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Search for other papers by Fang Liu in
Google Scholar
PubMed
accepted that hyperuricemia was considered to be a risk factor independent of other indicators for the development of incident chronic kidney disease (CKD) in type 2 diabetic mellitus (T2DM) patients with preserved kidney function ( 4 , 5 ). Furthermore